Cardiac function and architecture are maintained in a model of cardiorestricted overexpression of the prorenin-renin receptor

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Mahmud, Hasan ^a   Candido, Wellington Mardoqueu ^a   Van Genne, Linda ^a   Vreeswijk Baudoin, Inge ^a   Yu, Hongjuan ^a   Van De Sluis, Bart ^a   Van Deursen, Jan ^b,c   Van Gilst, Wiek H ^a   Silljé, Herman H W ^a   De Boer, Rudolf A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 47; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; CELL SURFACE RECEPTOR; CREATINE KINASE; ISOPRENALINE; LACTATE DEHYDROGENASE; PRORENIN RECEPTOR;

(P)RR GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HELA CELL; HYPOXIA; ISOLATED HEART; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; ANOXIA; BLOOD PRESSURE; CARDIOMEGALY; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART MUSCLE; HELA CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOOD PRESSURE; BLOTTING, WESTERN; CARDIOMEGALY; CREATINE KINASE; ECHOCARDIOGRAPHY; GENE EXPRESSION REGULATION; HEART; HELA CELLS; HUMANS; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; REPERFUSION INJURY;

EID: 84896110467     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089929     Document Type: Article

References (38)

1. Nguyen G, Muller DN (2010) The biology of the (pro)renin receptor. J Am Soc Nephrol 21: 18-23.
2. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, et al. (2002) Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417-1427. (Pubitemid 34596167)
3. Cuadra AE, Shan Z, Sumners C, Raizada MK (2010) A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? Pharmacol Ther 125: 27-38.
4. Nguyen G (2011) Renin and prorenin receptor in hypertension: what's new? Curr Hypertens Rep 13: 79-85.
5. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, et al. (2006) Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 17: 2495-503. (Pubitemid 44300965)
6. Kinouchi K, Ichihara A, Sano M, Sun-Wada GH, Wada Y, et al. (2010) The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res 107: 30-4.
7. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, et al. (2006) Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension47: 894-900. (Pubitemid 44297561)
8. Kaneshiro Y, Ichihara A, Takemitsu T, Sakoda M, Suzuki F, et al. (2006) Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int 70: 641-6. (Pubitemid 44215337)
9. Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, et al. (2007) Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 18: 1789-95. (Pubitemid 46870315)
10. Prieto MC, Williams DE, Liu L, Kavanagh KL, Mullins JJ, et al. (2011) Enhancement of renin and prorenin receptor in collecting duct of Cyp1a1-Ren2 rats may contribute to development and progression of malignant hypertension. Am J Physiol Renal Physiol 300: F581-8.
11. Mahmud H, Silljé HH, Cannon MV, van Gilst WH, de Boer RA (2012) Regulation of the (pro)renin-renin receptor in cardiac remodelling. J Cell Mol Med 16: 722-9.
12. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, et al. (2006) Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 17: 1950-61. (Pubitemid 44036179)
13. Ichihara A, Sakoda M, Kurauchi-Mito A, Kaneshiro Y, Itoh H (2008) Involvement of (pro)renin receptor in the glomerular filtration barrier. J Mol Med (Berl) 86: 629-35.
14. Burckle CA., Bader M Prorenin and its ancient receptor (2006) Hypertension 48: 549-551.
15. Burcklé CA, Jan Danser AH, Müller DN, Garrelds IM, Gasc JM, et al. (2006) Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 47: 552-6. (Pubitemid 43843874)
16. Moilanen AM, Rysä J, Serpi R, Mustonen E, Szabò Z, Aro J, et al. (2012) (Pro)renin receptor triggers distinct angiotensin II-independent extracellular matrix remodeling and deterioration of cardiac function. PLoS One 7: e41404.
17. Gulick J, Subramaniam A, Neumann J, Robbins J (1991) Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 266: 9180-5. (Pubitemid 21906635)
18. Buitrago M, Lorenz K, Maass AH, Oberdorf-Maass S, Keller U, et al. (2005) The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med 11: 837-44. (Pubitemid 41161115)
19. Kuipers I, van der Harst P, Kuipers F, van Genne L, Goris M, et al. (2010) Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system. Lab Invest 90: 630-6.
20. Cross HR, Lu L, Steenbergen C, Philipson KD, Murphy E (1998) Overexpression of the cardiac Na+/Ca2 + exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 83: 1215-23. (Pubitemid 29006036)
21. Meems LM, Cannon MV, Mahmud H, Voors AA, van Gilst WH, et al. (2012) The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol 132: 282-289.
22. Yu L, Ruifrok WP, Meissner M, Bos EM, van Goor H, et al. (2013) Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail 6: 107-17.
23. Chen S, Law CS, Grigsby CL, Olsen K, Hong TT, et al. (2011) Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation 124(17): 1838-47.
24. Kuipers I, Li J, Vreeswijk-Baudoin I, Koster J, van der Harst P, et al. (2010) Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo. Eur J Heart Fail 12(10): 1042-50.
25. Taglieri DM, Monasky MM, Knezevic I, Sheehan KA, Lei M,et al. (2011) Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. J Mol Cell Cardiol 51(6): 988-96.
26. Schroten NF, Gaillard CA, van Veldhuisen DJ, Szymanski MK, Hillege HL, et al. (2012) New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev 17: 191-201.
27. Batenburg WW, Krop M, Garrelds IM, de Vries R, de Bruin RJ, et al. (2007) Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens 25: 2441-53. (Pubitemid 350060383)
28. Nabi AH, Kageshima A, Uddin MN, Nakagawa T, Park EY, et al. (2006) Binding properties of rat prorenin and renin to the recombinant rat renin/ prorenin receptor prepared by a baculovirus expression system. Int J Mol Med 18: 483-8.
29. Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD (1996) Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 50: 1897-903. (Pubitemid 26417532)
30. Takahashi K, Hirose T, Mori N, Morimoto R, Kohzuki M, et al. (2009) The renin-angiotensin system, adrenomedullins and urotensin II in the kidney: possible renoprotection via the kidney peptide systems. Peptides 30: 1575-85.
31. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN (2008) The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol 19: 743-8.
32. Nguyen G. Renin, (pro)renin and receptor: an update (2011) Clin Sci (Lond) 120: 169-78.
33. van Esch JH, van Veghel R, Garrelds IM, Leijten F, Bouhuizen AM, et al. (2011) Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats. Hypertension 57: 852-8.
34. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, et al. (2010) Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 327: 459-63.
35. Takahashi K, Yamamoto H, Hirose T, Hiraishi K, Shoji I, et al. (2010) Expression of (pro)renin receptor in human kidneys with end-stage kidney disease due to diabetic nephropathy. Peptides 31: 1405-8.
36. Siragy HM, Huang J (2008) Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 93: 709-14. (Pubitemid 351595048)
37. Hirose T, Mori N, Totsune K, Morimoto R, Maejima T, et al. (2010) Increased expression of (pro)renin receptor in the remnant kidneys of 5/6 nephrectomized rats. Regul Pept 159: 93-9.
38. Batenburg WW, Lu X, Leijten F, Maschke U, Müller DN, et al. (2011) Reninand prorenin-induced effects in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor: does (pro)renin-(pro)renin receptor interaction actually occur? Hypertension 58: 1111-9.